Author: CATIE

Shame Canada: Canadian Task Force ignores expert advice in new hepatitis C screening guidelines

The Canadian Task Force on Preventative Health Care (CTFPHC) released its HCV Screening Guidelines today in the Canadian Medical Association Journal on Monday. To the dismay of experts across Canada including hepatitis C specialists, advocacy groups, and stakeholders, the new screening guidelines ignore expert advice regarding who should be tested for Hep C, setting a dangerous public health policy where dollars come first and the health of Canadians comes last.

Read more

Does price dictate HCV drug policy?

Early this year, British Columbia, Alberta, Saskatchewan, Quebec and Ontario announced the lowering of eligibility requirements for access to public coverage for life-changing hepatitis C drugs, including Epclusa, Zepatier, daclatasvir and asunaprevir. These drugs will be available to those with lower fibrosis scores for the first time (the greater the fibrosis score, the more severe the liver scarring, or cirrhosis, caused by disease.)[i]

Read more

Comment s’assurer que les actions de sécurité publique ne contreviennent pas à la mise en place de stratégies de réduction des méfaits ?

La transmission du VIH et du VHC constitue encore aujourd’hui un problème de santé publique de première importance.  Certains comportements, comme l’usage de drogues par injection et par inhalation, entraînent des risques importants de transmission. En effet, selon les données de surveillance [i], 15 % des personnes qui vont dans les centres d’accès au matériel d’injection et d’inhalation sont infectées au VIH et 63 % au VHC.

Read more

5 bonnes nouvelles à Ottawa pour le mieux-être des gars qui aiment les gars

À Ottawa, les gars gais, bisexuels, bispirituels, queer et d’autres gars qui aiment gars, que nous soyons cis ou trans (GBT2Q), avons de quoi être fiers. Ce sont des membres de nos communautés qui ont fondé MAX, le premier organisme avec un mandat de santé globale GBT2Q de l’Ontario (et le troisième au Canada). Cet hiver et ce printemps, voici cinq autres bonnes nouvelles pour le bien-être de nos communautés :

Read more

Women + PrEP: 5 Important Facts

The emergence of PrEP has highlighted important gender inequalities in HIV transmission and HIV prevention. PrEP, or pre-exposure prophylaxis, is a drug that HIV-negative people (including women!) can take to help prevent HIV; however, most discussions about PrEP focus on men. Despite representing fewer new HIV infections than men, women also need innovative HIV prevention methods.

Read more

Three reasons why CATIE supports U=U for sexual transmission

CATIE recently endorsed the Consensus Statement of the Prevention Access Campaign, celebrating the fact that “undetectable equals untransmittable.” This revolutionary statement, pushed forward by a dedicated group of people living with HIV, has prompted CATIE to reflect on our sexual HIV prevention messaging. The research on treatment as prevention has been slowly accumulating for many years. As an evidence-based organization, CATIE now recognizes that the evidence on undetectable viral load has reached a point where we are compelled to take our messaging a step further. We can comfortably say that when a person taking antiretroviral treatment has an ongoing undetectable...

Read more